- Report
- October 2025
- 192 Pages
Global
From €3151EUR$3,545USD£2,750GBP
€3501EUR$3,939USD£3,055GBP
- Report
- October 2025
- 183 Pages
Global
From €3151EUR$3,545USD£2,750GBP
€3501EUR$3,939USD£3,055GBP
- Report
- October 2025
- 190 Pages
Global
From €3151EUR$3,545USD£2,750GBP
€3501EUR$3,939USD£3,055GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1422EUR$1,600USD£1,241GBP
€1778EUR$2,000USD£1,551GBP
- Drug Pipelines
- April 2025
- 80 Pages
Global
From €1422EUR$1,600USD£1,241GBP
€1778EUR$2,000USD£1,551GBP
- Drug Pipelines
- April 2025
- 180 Pages
Global
From €1778EUR$2,000USD£1,551GBP
€2222EUR$2,500USD£1,939GBP
- Drug Pipelines
- April 2025
- 180 Pages
Global
From €2133EUR$2,400USD£1,861GBP
€2666EUR$3,000USD£2,327GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1067EUR$1,200USD£931GBP
€1333EUR$1,500USD£1,163GBP
- Report
- November 2025
- 180 Pages
Global
From €3999EUR$4,500USD£3,490GBP
- Report
- March 2025
- 200 Pages
Global
From €3991EUR$4,490USD£3,482GBP
- Report
- March 2025
- 200 Pages
Global
From €3991EUR$4,490USD£3,482GBP
- Clinical Trials
- April 2025
- 180 Pages
Global
From €1778EUR$2,000USD£1,551GBP
€2222EUR$2,500USD£1,939GBP
- Clinical Trials
- April 2025
- 240 Pages
Global
From €2133EUR$2,400USD£1,861GBP
€2666EUR$3,000USD£2,327GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1422EUR$1,600USD£1,241GBP
€1778EUR$2,000USD£1,551GBP
- Report
- December 2025
- 376 Pages
Global
From €5199EUR$5,850USD£4,537GBP
- Report
- December 2025
- 381 Pages
Global
From €5199EUR$5,850USD£4,537GBP
- Report
- December 2025
- 488 Pages
Global
From €5199EUR$5,850USD£4,537GBP
- Report
- December 2025
- 475 Pages
Global
From €5199EUR$5,850USD£4,537GBP
- Report
- December 2025
- 282 Pages
Global
From €5199EUR$5,850USD£4,537GBP
- Report
- December 2025
- 277 Pages
Global
From €5199EUR$5,850USD£4,537GBP

The Breast Cancer market is a subset of the Women's Health market, focusing on the diagnosis, treatment, and prevention of breast cancer. It includes a range of products and services, from medical devices and pharmaceuticals to patient education and support. Breast cancer is the most common cancer among women worldwide, and the market is driven by the need to improve early detection and treatment outcomes.
The Breast Cancer market is highly competitive, with a range of players from large multinationals to small start-ups. Companies in the market include Roche, Novartis, AstraZeneca, Pfizer, Merck, and Johnson & Johnson, as well as smaller players such as Myriad Genetics, Genomic Health, and Natera. Show Less Read more